Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2026-01-29 @ 4:54 PM
Study NCT ID:
NCT00913666
Status:
COMPLETED
Last Update Posted:
2009-06-04
First Post:
2009-06-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers
Sponsor:
Biogen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
C-863
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Biogen Idec MD
Old Organization:
Biogen Idec